Those with AKI not requiring RRT were more likely to have coronary artery disease (CAD) and be prescribed an angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) at baseline than those who did receive RRT. The gene discussed is ACE; the disease is acute kidney injury.